Flortaucipir F-18
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer's disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study.
Journal: Lancet (London, England)
Published: October 31, 2025
Artificial Intelligence in Alzheimer's Disease Diagnosis and Prognosis Using PET-MRI: A Narrative Review of High-Impact Literature Post-Tauvid Approval.
Journal: Journal of clinical medicine
Published: June 16, 2025
Revisiting the therapeutic landscape of tauopathies: assessing the current pipeline and clinical trials.
Journal: Alzheimer's research & therapy
Published: April 29, 2025
Development and Validation of a 18F-Flortaucipir PET Visual Stratification Method.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: August 28, 2024
Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 29, 2024
Role of Amyloidogenic and Non-Amyloidogenic Protein Spaces in Neurodegenerative Diseases and their Mitigation Using Theranostic Agents.
Journal: Chembiochem : a European journal of chemical biology
Published: March 11, 2024
Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
Journal: ACS chemical neuroscience
Published: September 16, 2022
Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 11, 2022
Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer's Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 08, 2021
Showing 1-12 of 12
Last Updated: 06/30/2026